Diversified Applications of Hydrocortisone Sodium Phosphate and Monothioglycerol Formulations

Publication ID: 24-11857555_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Diversified Applications of Hydrocortisone Sodium Phosphate and Monothioglycerol Formulations,” Published Technical Disclosure No. 24-11857555_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857555_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,555.

Summary of the Inventive Concept

The inventive concept leverages the core technology of the original patent to expand into new industries, including agriculture, food preservation, cosmetics, textiles, and water purification, by utilizing the unique properties of hydrocortisone sodium phosphate and monothioglycerol formulations.

Background and Problem Solved

The original patent focused on the development of an aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol for human therapeutic use. However, the formulation's potential applications extend far beyond pharmaceuticals. The inventive concept addresses the limitations of the original patent by exploring new industries and use cases that can benefit from the unique properties of these formulations.

Detailed Description of the Inventive Concept

The new claims describe the application of hydrocortisone sodium phosphate and monothioglycerol formulations in various industries. For instance, the formulation can be used in agriculture to enhance soil fertility and reduce soil erosion, in food preservation as a natural antimicrobial agent, in cosmetics to reduce skin inflammation and promote skin hydration, in textiles to improve fabric softness and durability, and in water purification to remove impurities and contaminants. The formulations' unique properties, such as their ability to reduce inflammation and promote hydration, make them ideal for these new applications.

Novelty and Inventive Step

The new claims introduce a significant inventive step by applying the core technology of the original patent to entirely new industries and use cases, which were not originally considered. The novelty of the inventive concept lies in the unexpected application of hydrocortisone sodium phosphate and monothioglycerol formulations in these new areas, which provides a unique solution to specific problems in each industry.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the concentration of hydrocortisone sodium phosphate and monothioglycerol, adding additional ingredients to enhance the formulations' properties, or modifying the manufacturing process to improve scalability and cost-effectiveness. These variations could further expand the potential applications of the inventive concept across different industries.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across various industries, including agriculture, food preservation, cosmetics, textiles, and water purification. The market for these applications is substantial, with potential customers including farmers, food manufacturers, cosmetic companies, textile producers, and water treatment facilities. The inventive concept's unique value proposition lies in its ability to provide sustainable, effective, and natural solutions to specific problems in each industry, making it an attractive option for companies looking to innovate and differentiate themselves.

Original Patent Information

Patent NumberUS 11,857,555
TitleAqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol
Assignee(s)Antares Pharma, Inc.